ENTO ENTERO THERAPEUTICS INC Earnings Reports 8-K Filing 2023 - Annual Meeting of Stockholders First Wave BioPharma, Inc. held its 2023 Annual Meeting of Stockholders and the stockholders voted on various proposals, including the election of directors, amendment to the equity incentive plan, approval of executive compensation, ratification of the appointment of an accounting firm, and approval of adjournment of the meeting.Get access to all SEC 8-K filings of the ENTERO THERAPEUTICS INC